[Results of cytostatic therapy of malignant hemoblastoses].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008206:Lymphatic Diseases / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010954:Plasmacytoma / Q000188:drug therapy; D011379:Prognosis; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents
Ergebnisse der zytostatischen Therapie maligner Hämoblastosen.